| Print
Novo Nordisk A/S (NOVO B)
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Address
Forecast key dates
| Name | Key Date |
|---|
Previous key dates
| Name | Key Date |
|---|